Correction Notice: Author Degree Misspelling in the Article "Whole-Blood Transfusion From Empiricism to Evidence: A Narrative Review
-
September 1, 2026
September 1, 2026
Scientific progress alone isn't enough, says Miguel Forte, who argues that reimbursement and patient access will shape the next decade of cell and gene therapy
by Miguel Forte
September 8, 2026
The Ascentage Pharma CEO on why next-generation small molecules are expanding into territory once reserved for biologics
September 15, 2026